307 related articles for article (PubMed ID: 15161980)
1. Sumoylation of heterogeneous nuclear ribonucleoproteins, zinc finger proteins, and nuclear pore complex proteins: a proteomic analysis.
Li T; Evdokimov E; Shen RF; Chao CC; Tekle E; Wang T; Stadtman ER; Yang DC; Chock PB
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8551-6. PubMed ID: 15161980
[TBL] [Abstract][Full Text] [Related]
2. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction.
Cooper HJ; Tatham MH; Jaffray E; Heath JK; Lam TT; Marshall AG; Hay RT
Anal Chem; 2005 Oct; 77(19):6310-9. PubMed ID: 16194093
[TBL] [Abstract][Full Text] [Related]
3. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins.
Song J; Durrin LK; Wilkinson TA; Krontiris TG; Chen Y
Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14373-8. PubMed ID: 15388847
[TBL] [Abstract][Full Text] [Related]
4. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies.
Sha Z; Blyszcz T; González-Prieto R; Vertegaal ACO; Goldberg AL
J Biol Chem; 2019 Oct; 294(42):15218-15234. PubMed ID: 31285264
[TBL] [Abstract][Full Text] [Related]
6. SUMO modification of heterogeneous nuclear ribonucleoproteins.
Vassileva MT; Matunis MJ
Mol Cell Biol; 2004 May; 24(9):3623-32. PubMed ID: 15082759
[TBL] [Abstract][Full Text] [Related]
7. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
Eisenhardt N; Chaugule VK; Pichler A
Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
[TBL] [Abstract][Full Text] [Related]
9. Dynamin interacts with members of the sumoylation machinery.
Mishra RK; Jatiani SS; Kumar A; Simhadri VR; Hosur RV; Mittal R
J Biol Chem; 2004 Jul; 279(30):31445-54. PubMed ID: 15123615
[TBL] [Abstract][Full Text] [Related]
10. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
[TBL] [Abstract][Full Text] [Related]
11. SUMOylation pathway in Trypanosoma cruzi: functional characterization and proteomic analysis of target proteins.
Bayona JC; Nakayasu ES; Laverrière M; Aguilar C; Sobreira TJ; Choi H; Nesvizhskii AI; Almeida IC; Cazzulo JJ; Alvarez VE
Mol Cell Proteomics; 2011 Dec; 10(12):M110.007369. PubMed ID: 21832256
[TBL] [Abstract][Full Text] [Related]
12. Roles of Sumoylation in mRNA Processing and Metabolism.
Richard P; Vethantham V; Manley JL
Adv Exp Med Biol; 2017; 963():15-33. PubMed ID: 28197904
[TBL] [Abstract][Full Text] [Related]
13. Mapping the SUMOylated landscape.
Eifler K; Vertegaal AC
FEBS J; 2015 Oct; 282(19):3669-80. PubMed ID: 26185901
[TBL] [Abstract][Full Text] [Related]
14. Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.
Saito Â; Souza EE; Costa FC; Meirelles GV; Gonçalves KA; Santos MT; Bressan GC; McComb ME; Costello CE; Whelan SA; Kobarg J
J Proteome Res; 2017 Sep; 16(9):3147-3157. PubMed ID: 28695742
[TBL] [Abstract][Full Text] [Related]
15. In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.
Saitoh N; Uchimura Y; Tachibana T; Sugahara S; Saitoh H; Nakao M
Exp Cell Res; 2006 May; 312(8):1418-30. PubMed ID: 16688858
[TBL] [Abstract][Full Text] [Related]
16. BCL11A is a SUMOylated protein and recruits SUMO-conjugation enzymes in its nuclear body.
Kuwata T; Nakamura T
Genes Cells; 2008 Sep; 13(9):931-40. PubMed ID: 18681895
[TBL] [Abstract][Full Text] [Related]
17. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.
Tatham MH; Kim S; Jaffray E; Song J; Chen Y; Hay RT
Nat Struct Mol Biol; 2005 Jan; 12(1):67-74. PubMed ID: 15608651
[TBL] [Abstract][Full Text] [Related]
18. Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS).
Niedenthal R
Methods Mol Biol; 2009; 497():63-79. PubMed ID: 19107411
[TBL] [Abstract][Full Text] [Related]
19. Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion.
Kim ET; Kim KK; Matunis MJ; Ahn JH
Biochem Biophys Res Commun; 2009 Oct; 388(1):41-5. PubMed ID: 19635459
[TBL] [Abstract][Full Text] [Related]
20. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S
J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]